Science ❯ Biotechnology

Vaccine Development

mRNA Technology Clinical Trials mRNA Vaccines Infectious Diseases Clinical Research Immunology Public Health Research COVID-19 mRNA Research COVID-19 Vaccines

MIT AI Identifies Excipient Mix That Makes mRNA Vaccines Stable at Room Temperature

If validated through manufacturing and regulation, the finding could remove cold‑chain barriers to wider vaccine distribution.

Yeast‑Made M2 Nanoparticle Vaccine Protects Mice From Multiple Flu Strains

FDA Advisers Unanimously Back Moderna’s mRNA Flu Vaccine

AI-Designed 'Super‑Antigen' Vaccine Passes Phase I Safety Test

Moderna Begins Phase III Trial of mRNA Bird Flu Vaccine in UK and US

WHO Sets 2026 Flu Vaccine Strains for Northern Hemisphere After H3N2 Variant Gains Ground

South Africa Launches First Locally Made Foot-and-Mouth Vaccine in 20 Years

CEPI Taps Samsung Biologics to Pre-Position Rapid Vaccine Manufacturing for Future Outbreaks

Pfizer Licenses Novavax’s Matrix‑M for Up to Two Vaccine Areas in Deal Worth Up to $530 Million

Denis Logunov Named Director of Russia’s Gamaleya Research Center

India Projects 2 Million Cancer Cases by 2040 as Government Touts Indigenous HPV Vaccine

mRNA COVID Vaccines Linked to Longer Survival With Cancer Immunotherapy, Nature Study Reports

Moderna Scraps CMV Vaccine Program After Phase 3 Failure

mRNA COVID Vaccination Linked to Longer Survival With Cancer Immunotherapy, Data Presented at ESMO

mRNA Allergy Vaccine Prevents Severe Reactions in Mice

Moderna Opens UK’s First Onshore mRNA Vaccine Plant at Harwell

HHS Axes $500 Million in BARDA mRNA Vaccine Projects, Drawing Intensifying Warnings

Membrane-Bound mRNA HIV Vaccine Elicits Neutralizing Antibodies in 80% of Participants

Moderna Cuts 10% of Global Workforce in Major Cost Overhaul

UF Researchers Develop Universal mRNA Vaccine That Primes Immune System Against Tumors